EFFECTS OF PENICILLINS ON BINDING OF PHENYTOIN TO PLASMA-PROTEINS INVITRO AND INVIVO

被引：10

作者：

ARIMORI, K ^{[1
]}

NAKANO, M ^{[1
]}

OTAGIRI, M ^{[1
]}

UEKAMA, K ^{[1
]}

机构：

[1] KUMAMOTO UNIV,FAC PHARMACEUT SCI,KUMAMOTO 862,JAPAN

来源：

BIOPHARMACEUTICS & DRUG DISPOSITION | 1984年 / 5卷 / 03期

关键词：

D O I：

10.1002/bdd.2510050304

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：219 / 227

页数：9

共 16 条

[1]

CHAM BE, 1982, J PHARMACOL EXP THER, V220, P648

[2]

DUSCI LJ, 1976, CLIN CHEM, V22, P1236

[3] MODIFICATION OF PHENYTOIN CLEARANCE BY VALPROIC ACID IN NORMAL SUBJECTS [J].

FRIGO, GM ;

LECCHINI, S ;

GATTI, G ;

PERUCCA, E ;

CREMA, A .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1979, 8 (06) :553-556

[4] TISSUE BINDING OF DRUGS [J].

GIBALDI, M ;

MCNAMARA, PJ .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1977, 66 (08) :1211-1212

[5]

HOOPER WD, 1974, CLIN PHARMACOL THER, V15, P276

[6] SPECTROPHOTOMETRIC INVESTIGATIONS OF THE INTERACTIONS OF PROTEINS WITH ORGANIC ANIONS [J].

KLOTZ, IM .

JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1946, 68 (11) :2299-2304

[7] PHENYTOIN-SALICYLATE INTERACTION [J].

LEONARD, RF ;

KNOTT, PJ ;

RANKIN, GO ;

ROBINSON, DS ;

MELNICK, DE .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 1981, 29 (01) :56-60

[8]

LUNDE PKM, 1970, CLIN PHARMACOL THER, V11, P846

[9] BINDING OF DRUGS BY PLASMA PROTEINS [J].

MEYER, MC ;

GUTTMAN, DE .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1968, 57 (06) :895-+

[10]

MOUKS A, 1978, BR J CLIN PHARM, V6, P487

← 1 2 →